SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: YOAV KEDAR who wrote (17)10/22/1996 9:14:00 AM
From: Thean   of 965
 
Bad news! Reopro growth is slowed again and does not appear to meet analyst's expectation.

LLY reported first nine months of Reopro's sales totalled $98 millions. They did not even try to break it down into this quarter's sales because the number is short of expectation.

Q1 $22.8 MM
Q2 $37.2 MM
Q3 $38.0 MM !!!

One published analyst estimate for Reopro revenue this quarter is $46MM!!! Reopro's growth rate is stalled for some reason. Would be interesting to see how CNTO reacts to this news when the market opens.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext